mog 35 55 peptide 55 Peptide - Myelin oligodendrocyte glycoprotein MOG The Crucial Role of MOG (35-55) Peptide in Understanding and Modeling Neurological Diseases

Mogcfa emulsion The MOG (35-55) peptide is a critical research tool, serving as a key epitope of the myelin oligodendrocyte glycoprotein (MOG).Background.MOG(35-55) is a truncatedpeptidederived from the human Myelin Oligodendrocyte Glycoprotein (MOG).MOG, a member of the immunoglobulin superfamily ... This peptide fragment, specifically amino acids 35 to 55 of the MOG protein, plays a pivotal role in the study of demyelinating disorders, most notably multiple sclerosis (MS).MOG (35-55) (mouse, rat) (trifluoroacetate salt) Researchers utilize the MOG peptide (35-55) to induce experimental autoimmune encephalomyelitis (EAE) in animal models, thereby gaining invaluable insights into the autoimmune processes that lead to neurological damage.作者：C Rich·2004·被引用次数：68—Moreover, Tg HLA-DR4-expressing mice injected with the myelin oligodendrocyte glycoprotein (MOG)-91–108peptidedevelopedpeptide-specific T ...

Understanding the MOG 35 55 peptide is essential for anyone involved in neuroscience research, immunology, and the development of therapeutic strategies for conditions affecting the central nervous system (CNS). The MOG (35-55) fragment is recognized as an immunodominant epitope, meaning it elicits a strong immune response, particularly from T cells. This characteristic makes it highly effective in triggering an autoimmune reaction that mimics aspects of human neurological diseases.

MOG (35-55) Peptide: A Gateway to EAE Research

The primary application of the MOG 35-55 peptide in scientific research is its ability to induce experimental autoimmune encephalomyelitis (EAE).Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced ... EAE is an animal model widely used to study the pathogenesis of demyelinating diseases like MS and MOG antibody disease (MOGAD)Immunizing mice withMOG(35-55)peptideto induce experimental autoimmune encephalomyelitis (EAE), it causes inflammation (macrophages and CD3+ T lymphocytes), .... When animals, typically mice or rats, are immunized with the MOG 35-55 peptide, it triggers an autoimmune response against the myelin sheath, the protective covering around nerve fibers in the CNS.

This induced autoimmune response leads to significant neurological symptoms, including inflammation, infiltration of immune cells such as macrophages and CD3+ T lymphocytes into the CNS, and crucially, a relapsing-remitting neurological disease with extensive plaque-like demyelination. This latter characteristic closely mirrors the pathological hallmarks observed in human multiple sclerosis. The MOG (35-55) peptide has been shown to induce autoantibody production and relapsing-remitting neurological disease in various animal models.MOGProtein35-55is used as an antigen/immunogen to induce anti-MOGantibodies to induce experimental diseases such as experimental autoimmune ... Studies have demonstrated that this peptide is able to induce a model of demyelinating of the myelin sheath: EAE (Experimental autoimmune encephalomyelitis).

Scientific Applications and Research Insights

The use of MOG (35-55) extends beyond just inducing EAE.MOG(35-55) producesa relapsing-remitting neurological disease with extensive plaque-like demyelination, common to the manifestations of multiple sclerosis. It enables researchers to explore specific cellular and molecular mechanisms involved in autoimmune diseasesMyelin Oligodendrocyte Glycoprotein(35-55), rat MOG(35-55). For instance, scientists can investigate:

* T cell responses: The MOG 35-55 peptide is ideal for T cell assays, allowing researchers to characterize the types of T cells involved in the autoimmune attack and their specific responses to the MOG antigen. Studies have shown that the MOG 35-55 peptide induces strong T and B cell responses.

* Autoantibody production: The MOG protein 35-55 can be used as an antigen or immunogen to induce anti-MOG antibodies, which are crucial in understanding the humoral immune response in demyelinating conditions.

* Therapeutic interventions: By studying EAE models induced by MOG (35-55), researchers can test the efficacy of potential new treatments.Human (MOG 1-125) and (MOG-35-55) Myelin Oligodendrocyte Glycoprotein-Induced ... InMOG35–55 peptide-induced EAE, B cells do not become activated or ... For example, research has explored how intravenous administration of MOG35-55 peptide can inhibit EAE by suppressing specific signaling pathways like IL-17/STAT4. Other studies have investigated compounds like OM-MOG35-55, a mannan-conjugated peptide, for its ability to suppress antigen-specific T cell responses associated with autoimmune demyelination.Human (MOG 1-125) and (MOG-35-55) Myelin ...

The MOG Protein and its Significance

Myelin oligodendrocyte glycoprotein (MOG) is a protein expressed in the CNS that plays a role in myelin maintenance and repair. In certain autoimmune conditions, the immune system mistakenly targets MOG, leading to the destruction of the myelin sheath. While the full MOG protein is complex, the MOG (35-55) fragment represents a particularly reactive part of the molecule. This fragment is derived from the human Myelin Oligodendrocyte Glycoprotein (MOG), a member of the immunoglobulin superfamily.

The sequence of the MOG (35-55) peptide, often represented as MEVGWYRPPFSRVVHLYRNGK, is a specific and vital piece of information for researchers working with this antigen. This MOG peptide fragment is a minor component of CNS myelin, yet its immunogenicity makes it a powerful toolMOG (35-55) (human).

Variations and Related Entities

While MOG (35-55) is the most commonly studied fragment, it's important to note variations and related entities in research:

* MOG (35-55) human and MOG (35-55) mouse/rat: Different species' MOG sequences can have slight variations, and researchers often use species-specific peptides depending on their experimental models.

* MOG Antibody Disease (MOGAD): This is a distinct autoimmune neurological disorder where antibodies specifically target MOG. While related to MS, it has its own set of symptoms and treatment approaches, and MOG (35-55) is instrumental in modeling this condition.

* Myelin oligodendrocyte glycoprotein associated diseases: This is a broader category encompassing conditions where MOG is implicated in the disease process.

* Related searches for terms like "Mog3555 sequence," "Myelin oligodendrocyte glycoprotein," and specific chemical compounds like "Mogcfa emulsion" reflect the diverse research avenues stemming from the core MOG (35-55) peptide.

In summary, the MOG (35-55) peptide is an indispensable component in the scientific community's efforts to unravel the complexities of demyelinating diseasesMyelin Oligodendrocyte Glycoprotein (MOG)35–55 .... Its ability to reliably induce experimental autoimmune encephalomyelitis provides a crucial platform for understanding disease mechanisms, identifying biomarkers, and developing effective therapeutic interventions for conditions that severely impact neurological function.MOG (35-55), mouse, rat The detailed study of this MOG peptide 35 and its associated immune responses continues to advance our knowledge of neurological health and disease.